Kevin J. Harrington
Molecular Biology · 2009–2020
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 91 citations into it
- Cancer Research — 32 citations into it
Whom Kevin J. Harrington trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Rakesh K. Jain (in Molecular Biology)
Papers from Kevin J. Harrington's perspective
Ordered by how strongly the researchers Kevin J. Harrington trusts endorse each paper. Same corpus, a different order for every researcher.
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- The present and future role of microfluidics in biomedical research (Nature)
- Innovation: Metabolomics: the apogee of the omics trilogy (Nature reviews. Molecular cell biology)
- Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. (Annual Review of Cell and Developmental Biology)
- Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor (EMBO Journal)
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. (Molecular Therapy)
- The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. (Developmental Biology)
- The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. (Clinical Chemistry)
- In vitro microvessels for the study of angiogenesis and thrombosis (Proceedings of the National Academy of Sciences of the United States of America)
- Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Their papers
- The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence (2015) — 1,909 citations
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) — 916 citations
- Inflammatory microenvironment remodelling by tumour cells after radiotherapy (2020) — 746 citations
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression (2018) — 691 citations
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. (2015) — 2,318 citations
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial (2011) — 1,607 citations
- Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. (2009) — 623 citations